ABSTRACT
Introduction
Childhood type 1 diabetes (T1D) is a rising global public health concern, both in developing and economically developed countries. Nowadays, there are 1.94 billion children living all over the world and total 586.000 of children and adolescents below 15 years of age are estimated to have T1D globally. Furthermore, approximately 96.000 new cases of T1D are diagnosed in children aged 0-14 years each year [1] . The overall trend across the world is still upwards according to the epidemiological data on the childhood T1D prevalence, with the most pronounced increase in the youngest age group [2] [3] [4] [5] . Similarly, in Poland the epidemiological trend is alerted, based on our data from Wielkopolska area, the incidence rate of T1D in children aged 0-14 years increased almost six-fold from 4.2/10 5 /year in the early 1970s to 24.3/10 5 /year in 2013 [6] . Witnessed situation has a great impact on children's health since T1D is related not only to long-term complications, but also to short-term consequences, for instance, at diagnosis time. Diabetic ketoacidosis (DKA), one of the most life-threatening severe T1D complications, is highly prevalent in newly diagnosed pediatric patients and its frequency at diagnosis varies from 12.8% to 80% depending on a geographic location [7] . Moreover, younger children, aged < 5 years, are at greater risk of developing DKA [8] [9] [10] [11] .
On the one hand, the most common rare and primary fatal complication of DKA is a cerebral oedema occurring in 0.3-1% patients at disease onset, as a result of that DKA is considered as a leading cause of diabetes-related death in children with the mortality rate estimated to be at about 0.15-0.3% [12] [13] [14] . On the other hand, DKA has a negative influence on a residual b-cell function, therefore, patients with DKA at T1D onset had a lower partial remission incidence in the first six months after diagnosis [15] , less a residual b-cell function and have a worse metabolic control [16] . Those individuals who developed partial remission had significantly lower level of low-density lipoprotein (LDL) 5 years after T1D diagnosis [17] .
Commonly, risk factors for DKA in children with newly diagnosed T1D include: young age (< 5 years), diagnostic error and delayed treatment, lack of health insurance (USA), lower socioeconomic status, preceding infection, whereas, factors such as first degree relative with T1D, higher parental education and higher background incidence of T1D are consider as a protective factors [8] [9] [10] 14] .
Despite the fact that both the initial symptoms of T1D and the diagnostic criteria are well defined, frequently children are misdiagnosed at the diabetes onset. Particularly, this situation has been observed in infants and toddlers where obtaining the history of classic trio of symptoms, such as polyuria, polydipsia or weight loss, compering to adolescents or young adults is challenging. In young pediatric population frequently the first clinical manifestation is blurred, therefore, the most common diagnostic errors are: respiratory tract disease (46.3%), vaginal candidiasis (16.6%), gastroenteritis (16.6%), urinary tract infection (11.1%), gastritis (11.1%) and appendicitis (3.7%) [11] . Consequently, due to delayed diagnosis or diagnostic error combined with an inadequate treatment children are more prone to develop severe dehydration and acidosis, which ultimately could lead to cerebral oedema [4] .
Regarding the accelerated epidemiological trend of shifting the peaks of age at T1D diagnosis toward younger age groups it seems to be reasonable to evaluate current DKA frequency and investigate factors associated with its presence at the T1D onset in children. Understanding factors which are associated with DKA occurrence at diagnosis may help to decrease the number of children presenting with severe DKA, thereby, it could contribute to reducing acute complications and the risk of death at T1D onset.
The purpose of this study was to identify the prevalence of DKA and factors related to its occurrence in children and adolescents at T1D diagnosis from Wielkopolska province, Poland.
Material and methods

Data collection
The 
Diabetes diagnosis
Diabetes was diagnosed based upon WHO criteria, including fasting plasma glucose ≥ 126 mg/dl (7.0 mmol/l), 2-h postprandial plasma glucose ≥ 200 mg/dl (11.1 mmol/l), during an oral glucose tolerance test, classic symptoms of hyperglycemia or hyperglycemic crisis, as well as random plasma glucose concentration of ≥ 200 mg/dl (11.1 mmol/l). The first day of insulin administration was at T1D diagnosis.
Clinical and laboratory data
Standard laboratory tests, including blood glucose, capillary blood gases and blood or urinary ketones were performed in every patient. DKA was defined as blood glucose concentration > 250 mg/dl (13.9 mmol/l), blood pH < 7.30, concentration of HCO3 < 15 mmol/l, detection of ketones in the urine or elevated ketones in the serum, anion gap > 12. It was considered as mild, moderate and severe if pH was < 7.3 ≥ 7.2, < 7.2 ≥ 7.1 and < 7.1, respectively. According to the obtained results, children were divided into two groups: non DKA group and DKA group. Fasting C-peptide and insulin levels were evaluated as a measurement of residual b-cell function at T1D onset. The blood samples were collected before an initial insulin therapy and assayed by the clinical laboratory immediately after the samples were obtained. C-peptide concentration was analysed using radioimmunoassay (C-PEP II-RIA-CT, DIAsource Immunoassay, S.A, Louvain-la-Neuve, Belgium), with the normal range: 0.59-1.54 pmol/ml, while insulin level was assessed by Chemiluminescent Microparticle Immunoassay (The Insulin ARCHITECT System, Abbott Laboratories, Illinois, USA), with the fasting normal range < 15 uU/ml. Glycated haemoglobin (HbA 1c ) was measured using NGSP-certified method (HbA 1c ARCHI-TECT System, Abbott Laboratories, Illinois, USA) with non-diabetic values < 5.7%. To confirm autoimmune diabetes origin typical autoantibodies were tested. Autoantibodies against glutamic acid decarboxylase (GADA) and antibodies to tyrosine phosphatase-like antigen (IA-2) were measured by ELISA kits. The normal reference range for GAD-ab and IA2-ab was ≤ 1 U/mL (Anti-Glutamic Acid Decarboxylase (GAD) and Anti-Tyrosine Phosphatase (IA2) (RIA EUROIMMUN, Lubeck, Germany). Insulin autoantibodies (IAA) were measured by immunoassays with the normal reference range < 5.5% (AIA-100, DIAsource Immunoassay, S.A, Louvain-la-Neuve, Belgium). Additionally, 219 patients were tested to autoantibodies to zinc transporter-8 (ZnT8-ab) level using enzyme-linked immunosorbent assay. The upper limit of the normal range was 15 U/mL (Elisa ZnT8 AbTM, RSR, Cardiff, United Kingdom).
A questionnaire on diabetes from first symptom(s) to diagnosis was completed by children's caregivers. Factors affecting the risk of DKA development such as age, sex, residence (urban vs. rural), symptoms duration, initial diagnosis, socioeconomic status, parental education, first degree relative with T1D were investigated in all study population. The lack of health insurance was not considered as a risk factor, because insured and uninsured children have the same access to the medical care in Poland.
The data was divided into four age groups: 0-4, 5-9, 10-14 and 14-18 years. Four patients were excluded from our study: two with neonatal diabetes, one with MODY 2 and one with T2D.
Statistical methods
All data are expressed as mean standard deviations (± SD), unless otherwise stated. The analysed data came from the interval and nominal scale. Student's t-test was used to compare the two groups, and the Mann-Whitney test was applied in case of data does not follow a normal distribution. The assumption of normality was checked by Kolmogorov-Smirnov test. Nominal data were analysed with the c 2 test or Fisher's exact test. When more than two groups were compared simultaneously, univariate analysis of variance with the Tukey post-hoc test was performed. All tests were analysed at the significance level of a = 0.05. Statistical analysis was performed using Statistica 10.0 software (Stat Soft Inc, Tulsa, USA).
Results
During six years of our study we identified 735 new cases of T1D in children aged 0-18 years from Wielkoposka province. The frequency of T1D diagnosis among both genders was comparable and it was reported in 329 girls (44.7%) and 406 boys (55.3%). The mean age at diagnosis was 9.3 years (SD ± 4.5). Laboratory results are shown in Table 1 .
DKA was diagnosed in 36% of patients with newly diagnosed T1D (n = 267), of whom 12.9% (n = 95) developed mild, 14.5% moderate and 8.6% severe (Table 1) . There was no difference in the frequency of DKA between girls and boys (49.3% vs. 50.7%). When comparing studied age groups it was noted that the occurrence of DKA was higher in younger individuals. In children aged 0-4, 5-9, 10-14 and 15-18 years DKA was present in 82 (48.5%), 90 (34.7%), 72 (31.4%) and 22 (28.2%) cases, respectively. In the youngest group aged < 4 years it occurred significantly more often (p = 0.001). Comparable severity of DKA was observed in all age-groups. Mostly mild or moderate DKA was diagnosed (Figures 1, 2) .
Blood ketones, blood glucose and HbA 1c levels were significantly higher in children with DKA compared to children without it at diagnosis time (p = 0.0001, p = 0.00001, p = 0.0004, respec- HbA 1c -glycated haemoglobin; DKA -diabetic ketoacidosis tively), while insulin and C-peptide levels were lower (p = 0.0001 and p = 0.0001, respectively) ( Table 2) . Two major risk factors responsible for a greater prevalence of DKA were reported in children with newly diagnosed T1D. The highest DKA frequency was associated with longer symptoms' duration (> 28 days) (p = 0.014) and initiall diabetes misdiagnosis (p = 0.001) ( Table 2) . While, factors such as rural or urban residence, sex, pre-hospitalisation, parental education, lower socioeconomic status or first degree relative with T1D did not affect DKA occurrence in our study.
At T1D onset the spectrum of antibodies and their correlations to DKA presence were investigated. ZnT8--ab was detected significantly more often in children with DKA compared to children without DKA (p = = 0.044). Moreover, significantly higher titers of ZnT8--ab [448.0 (25.7-524.5) vs. 284.3 (49.5-524.5) U/ml, p < 0.039] were found among individuals with DKA. There was no relationship between DKA presence or its severity and other typical autoantibodies (Table 3) .
Discussion
Undeniably, the frequency of DKA at the T1D onset in Poland is unacceptably high. This is reflected not only in our study, which showed that 36% of children presented DKA at the diagnosis time, but also other reports from Poland confirmed our findings [18, 19] . There are many possible reasons responsible for observed situation.
First of all, recently the dynamic changes in childhood T1D prevalence has been observed in Poland. The incidence of T1D has increased almost six-fold since the first epidemiological studies conducted in the early 1970s in Wielkopolska province, with the current incidence rate estimated at around 24.3/10 5 /year in children under 15 years [6] . Likewise, the growing number of children with newly diagnosed T1D was reported in the other regions of Poland [20] [21] [22] . Despite the fact that T1D is one of the most common chronic diseases occurring in pediatric population it was shown that physicians-related factor, such as misdiagnosis at the first medical consultation, may play a key role in DKA development in children at T1D onset. Diagnostic error was previously reported as a factor having a negative impact on DKA occurrence. Several studies showed that children not recognised to have T1D onset at first medical visits had threefold increased risk of presenting in DKA. This risk was independent of the presence or absence of infection preceding diagnosis, however, misdiagnosis occurred more frequently in younger children [8] . Similarly, this study demonstrated that the delayed diagnosis and symptoms' duration longer than 28 days are positively correlated with the higher occurrence of DKA in children at disease onset. Our findings suggest that many primary care physicians and pediatricians may have difficulties in recognising this condition or are not aware of the possibility of diabetes diagnosis in children, as a consequence, it contributes to treatment delay. Probably, health providers are unfamiliar with T1D due to previously reported low T1D incidence rate among Polish children, therefore, T1D might be still consider as a rare disease in pediatric population. As a result of that, not only children living in countries with low prevalence of T1D are at risk of developing of DKA at disease onset, but also those living in countries with rapid changes in T1D incidence.
Secondly, age-related differences in the frequency of DKA at T1D onset was observed in this study, subsequently, almost half of children aged 0-4 developed DKA, as opposed to older individuals who had a lower prevalence of DKA. Comparable high frequency of DKA in younger children with new-onset diabetes was reported from other studies worldwide [7, 9, 10, 12] . It seems to be important, because common signs of T1D often resemble symptoms of other disease. Particularly, young children could present asymptomatic manifestation of disease, therefore, they may be misdiagnosed as having pneumonia, reactive airways disease (asthma) or bronchiolitis [11] . Consequently, those children receive an inappropriate treatment, such as glucocorticoids and/or sympathomimetic drugs, which aggravate the metabolic disorder. Again, physicians should be aware of the possibility of diabetes occurrence in young children, particularly when the peak incidence is still shifting to a younger age [1, 2, 4, 5] . On the one side, concomitant illness, especially infections, may cause an increased insulin requirement and, thereby may provoke a faster decompensation of already affected by the destructive process b-cell function leading to accelerated disease manifestation. As a result of that, it is reasonable to put more effort on medical education, because primary care physicians may help in reducing number of children presenting in DKA.
On the other side, occurrence of DKA is not only associated with acute complications at disease onset, but also it might influence later clinical course of T1D, particularly in terms of entering a remission phase. There are several clinical and metabolic factors interfering the presence and length of the remission period, which depends partly on the recovery of b-cell function [23] . Neylon et al. demonstrated that children who experienced moderate or severe DKA at T1D diagnosis are less likely to develop a partial remission phase and their honeymoon period is shorter compared to those without DKA at disease onset [24] . Moreover, younger age at diagnosis is related to the worst preserved b-cell function, consequently, children under 2 years of age had a negligible chance to develop honeymoon phase and even if, the duration of this stage was shorter than in children over 5 years of age [15, 23] . Therefore, thus indicates that the higher frequency of DKA and younger age at diagnosis could be associated with more aggressive b-cell destruction process and less residual insulin secretion at the time of diagnosis. Similarly, we reported that children with DKA had greater decline of b-cell function compared to individuals without DKA at T1D onset. Then, residual insulin secretion may have a negative impact on partial remission incidence or glycaemia control in those with DKA, nevertheless, the limitation of this study is the lack of stimulated C-peptide levels measurement and further follow-up.
Regarding autoimmune markers, we investigated correlation between typical T1D autoantibodies and DKA presence in children at the disease onset. Interestingly, higher occurrence and titers of ZnT8-ab were reported more frequently in those who were diagnosed with DKA. We did not find any associations between other autoimmune markers and DKA diagnosis. Relationship between presence of ZnT8-ab and severity of diabetes clinical manifestation is still ambiguous. However, ZnT8-ab is highly b-cells specific compared to other autoimmune markers. ZnT8 is an autoantigen, exclusively expressed in insulin containing secretory granules of pancreatic b-cells [25] . Our findings might suggest that Znt8-ab is associated with a strong autoimmune attack and more aggressive autoimmune damage of b-cell population.
Finally, it seems plausible that the correlation between insulin resistance and T1D clinical manifestation exists. Assuming that insulin resistance increases with aging and the normal growth, especially during puberty period, young adults and teenager are more insulin resistant compared to younger children. Consequently, at T1D onset destructive process is not yet advanced and there are still existing b-cells with preserved function. In such a situation older children may present T1D initial symptoms earlier and slower, which may prevent DKA development at T1D diagnosis. This hypothesis seems to be applicable due to increasing number of overweight and obese children with unclear diabetes diagnosis [26, 27] . In contrast, younger children are characterized by a high insulin sensitivity which may delay T1D symptoms occurrence to the moment when b-cells destruction has reached their critical deficit. Perhaps, it explains highest DKA prevalence at T1D diagnosis in young children.
To conclude, the frequency of DKA in newly diagnosed with T1D children was significant in this region of Poland. More than one-third of T1D children were presented with DKA at the diagnosis time. There was correlation between diabetes misdiagnosis, symptoms' duration, age under 4 years and presentation at DKA state. Severity of DKA was particularly substantial in the youngest children. ZnT8-ab is associated with the worst general condition at T1D onset. In the face of increasing incidence of T1D, especially in the youngest children, the pediatricians and general practitioners require further education about diabetes presentation in children of different age and possible diagnostic errors.
Study limitations
Some limitations should be taken into account when interpreting the results of this study. ZnT8-ab assessment was not performed in all study population, consequently, the analysis might not reflect exact clinical meaning of these autoantibodies and their role in autoimmune process. Another weakness of this study was carrying out the analysis only among children and adolescents from Wielkopolska province, then, findings may not represent DKA prevalence at T1D onset in all polish pediatric population. Moreover, the effect of DKA on partial remission was not investigated in this study, because we did not evaluate stimulated C-peptide levels and we not followed-up study participants. Finally, some additional potential factors influencing DKA prevalence were not assessed in this study such as family structure, time of the year, pattern and frequency of symptoms, preceding infections or febrile illnesses, which have previously been found to affect DKA occurrence in some although not all studies in children and adolescents.
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